Dalla Chiesa M, Passalacqua R, Michiara, et al. M. Tamoxifen vs Tamoxifen plus 13-cis-retinoic acid vs Tamoxifen plus Interferon a–2a as first-line endocrine treatments in advanced breast cancer: updated results of a phase II, prospective, randomised multicentre trial. Acta Biomed [Internet]. 2007 Dec. 1 [cited 2024 Jul. 27];78(3):204-9. Available from: https://mattioli1885journals.com/index.php/actabiomedica/article/view/1903